Cargando…
COVID-19: The therapeutic landscape
Therapeutics for hospitalized COVID-19 patients were identified through a robust research response with several lessons learned: clinical trial data should guide therapeutic use, results should not be extrapolated between disease stages, and robust studies should be designed to give clinically relev...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057546/ https://www.ncbi.nlm.nih.gov/pubmed/33899041 http://dx.doi.org/10.1016/j.medj.2021.04.015 |
| _version_ | 1783680859719598080 |
|---|---|
| author | Paules, Catharine I. Fauci, Anthony S. |
| author_facet | Paules, Catharine I. Fauci, Anthony S. |
| author_sort | Paules, Catharine I. |
| collection | PubMed |
| description | Therapeutics for hospitalized COVID-19 patients were identified through a robust research response with several lessons learned: clinical trial data should guide therapeutic use, results should not be extrapolated between disease stages, and robust studies should be designed to give clinically relevant data. These lessons should be applied to the outpatient research response. |
| format | Online Article Text |
| id | pubmed-8057546 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80575462021-04-21 COVID-19: The therapeutic landscape Paules, Catharine I. Fauci, Anthony S. Med (N Y) Commentary Therapeutics for hospitalized COVID-19 patients were identified through a robust research response with several lessons learned: clinical trial data should guide therapeutic use, results should not be extrapolated between disease stages, and robust studies should be designed to give clinically relevant data. These lessons should be applied to the outpatient research response. Elsevier Inc. 2021-05-14 2021-04-20 /pmc/articles/PMC8057546/ /pubmed/33899041 http://dx.doi.org/10.1016/j.medj.2021.04.015 Text en © 2021 Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Commentary Paules, Catharine I. Fauci, Anthony S. COVID-19: The therapeutic landscape |
| title | COVID-19: The therapeutic landscape |
| title_full | COVID-19: The therapeutic landscape |
| title_fullStr | COVID-19: The therapeutic landscape |
| title_full_unstemmed | COVID-19: The therapeutic landscape |
| title_short | COVID-19: The therapeutic landscape |
| title_sort | covid-19: the therapeutic landscape |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057546/ https://www.ncbi.nlm.nih.gov/pubmed/33899041 http://dx.doi.org/10.1016/j.medj.2021.04.015 |
| work_keys_str_mv | AT paulescatharinei covid19thetherapeuticlandscape AT faucianthonys covid19thetherapeuticlandscape |